Keytruda 50 MG Injection

RxCUI
1657749
RxNorm name
Keytruda 50 MG Injection
Display name
Keytruda 50 MG Injection
Full name
Keytruda 50 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125514Keytrudapembrolizumab351(a)Disc2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KEYTRUDAPEMBROLIZUMABMerck Sharp & Dohme LLC9333c79b-d487-4538-a9f0-71b91a02b2872026-07-10Warnings, Adverse reactionsExact identifier
rxcui: 1657749

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9333c79b-d487-4538-a9f0-71b91a02b287Keytruda 50 MG InjectionPSN225These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 201420260512
9333c79b-d487-4538-a9f0-71b91a02b287Keytruda 50 MG InjectionSY225These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 201420260512
9333c79b-d487-4538-a9f0-71b91a02b287pembrolizumab 50 MG Injection [Keytruda]SBD225These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 201420260512